REIMBURSEMENT UNRAVELLED: Bridging the gap with Germany’s NUB program
This article was originally published in Clinica
Executive Summary
Companies need no longer fear the reimbursement dead zone that new and costly technologies seem to find themselves in. The German NUB (Neue Untersuchungs- und Behandlungsmethoden) process is intended to allow for temporary additional reimbursement of these innovations in the German inpatient sector. In this third article in Clinica’s medtech reimbursement series, Medalliance’s Ben Modley explains the NUB concept and how it fits into the wider German DRG system